Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Intraventricular Administration of Rituximab in Combination With Methotrexate in the Treatment of Recurrent CNS and Intraocular Lymphoma

NCT00221325 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00221325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00221325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Intraventricular Administration of Rituximab in Combination With Methotrexate in the Treatment of Recurrent CNS and Intraocular Lymphoma
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2007
Completion date
March 31, 2013
Enrollment
14 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system lymphoma, intraocular lymphoma